Changes in lung volume and ventilation during surfactant treatment in ventilated preterm infants. 2011

Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
Department of Neonatology (H3-214), Emma Children's Hospital AMC, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands. m.miedema@amc.uva.nl

BACKGROUND The immediate and regional effects of exogenous surfactant in open lung high-frequency oscillatory ventilated (HFOV) preterm infants are unknown. OBJECTIVE To assess regional changes in lung volume, mechanics, and ventilation during and after surfactant administration in HFOV preterm infants with respiratory distress syndrome (RDS). METHODS Using electrical impedance tomography, changes in lung volume were continuously recorded during a stepwise recruitment procedure before, during, and after surfactant administration in 15 preterm infants (gestational age: 28.3 wk; birth weight: 1,000 g). Deflation limbs of the pressure-impedance curve before and after surfactant were mapped and the effect of surfactant on oscillation volumes and ventilation was determined. Data were analyzed for the whole cross-section and the left, right, ventral, and dorsal lung regions. RESULTS Surfactant increased lung volume by 61 ± 39% within a median time of 241 seconds. The ventral to dorsal ratio in lung volume changed significantly from 1.16 before to 0.81 after surfactant administration. The upper inflection point of the deflation limb after surfactant (10.4 ± 2.4 cm H(2)O) was significantly lower compared with before surfactant (16.4 ± 3.1 cm H(2)O). Surfactant increased maximal compliance of the respiratory system, and this effect was reached at lower airway pressures. Surfactant caused a transient decrease in oscillatory volume but did not alter its regional distribution. CONCLUSIONS Surfactant treatment in HFOV preterm infants with RDS causes a rapid increase and subsequent stabilization of lung volume, which is most prominent in dependent lung regions. It increased maximal compliance, but this effect is only reached at lower airway pressures.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D008170 Lung Compliance The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562) Compliance, Lung,Compliances, Lung,Lung Compliances
D008176 Lung Volume Measurements Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle. Lung Capacities,Lung Volumes,Capacity, Lung,Lung Capacity,Lung Volume,Lung Volume Measurement,Measurement, Lung Volume,Volume, Lung
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D012123 Pulmonary Ventilation The total volume of gas inspired or expired per unit of time, usually measured in liters per minute. Respiratory Airflow,Ventilation Tests,Ventilation, Pulmonary,Expiratory Airflow,Airflow, Expiratory,Airflow, Respiratory,Test, Ventilation,Tests, Ventilation,Ventilation Test
D012127 Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. Infantile Respiratory Distress Syndrome,Neonatal Respiratory Distress Syndrome,Respiratory Distress Syndrome, Infant
D006612 High-Frequency Ventilation Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation (HFPPV); HIGH-FREQUENCY JET VENTILATION; (HFJV); and high-frequency oscillation (HFO). High-Frequency Oscillation Ventilation,High-Frequency Positive Pressure Ventilation,Ventilation, High-Frequency,High Frequency Oscillation Ventilation,High Frequency Positive Pressure Ventilation,High Frequency Ventilation,Ventilation, High Frequency,High Frequency Ventilations,High-Frequency Oscillation Ventilations,High-Frequency Ventilations,Oscillation Ventilation, High-Frequency,Oscillation Ventilations, High-Frequency,Ventilation, High-Frequency Oscillation,Ventilations, High Frequency,Ventilations, High-Frequency,Ventilations, High-Frequency Oscillation

Related Publications

Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
March 2023, Archives of disease in childhood. Fetal and neonatal edition,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
June 1992, Neuropediatrics,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
September 1994, Pediatric pulmonology,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
July 1993, Archives of disease in childhood,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
November 2008, Archives of disease in childhood. Fetal and neonatal edition,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
January 2009, PloS one,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
January 2012, Acta bio-medica : Atenei Parmensis,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
September 1992, Pediatric pulmonology,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
July 2008, Archives of disease in childhood. Fetal and neonatal edition,
Martijn Miedema, and Frans H de Jongh, and Inez Frerichs, and Mariëtte B van Veenendaal, and Anton H van Kaam
October 1993, The American review of respiratory disease,
Copied contents to your clipboard!